1 / 45

Expert Consultation on Infectiousness of Organisms Studied in the NEIDL Risk Assessment

Expert Consultation on Infectiousness of Organisms Studied in the NEIDL Risk Assessment. Sam A Bozzette, MD, PhD Adi Gundlapali , MD, PhD. May 18, 2010. Overview. Delphi process Informed voting Feedback of group and your own responses Opportunity for discussion

etana
Télécharger la présentation

Expert Consultation on Infectiousness of Organisms Studied in the NEIDL Risk Assessment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Expert Consultation on Infectiousness of Organisms Studied in the NEIDL Risk Assessment Sam A Bozzette, MD, PhDAdi Gundlapali, MD, PhD May 18, 2010

  2. Overview • Delphi process • Informed voting • Feedback of group and your own responses • Opportunity for discussion • Re-voting with feedback • Where are we? • Background information distributed • One round of voting complete • Voting analyzed and feedback prepared

  3. Today • Distribute feedback materials • Summary of all votes • Your own vote • By section • Review and discuss the background material • Review feedback • Re-vote on paper forms

  4. Infectious Dose • Inhalation • Percutaneous (sharps) • Mucous membranes • Ingestion • Animal or arthropod Accident event/transmission route 4

  5. Infectious Dose • Inhalation • Percutaneous (sharps) • Mucous membranes • Ingestion • Animal or arthropod Accident event/transmission route Amount, concentration, form of pathogen • The “source term” • Working cultures • Inocula for animal challenges 5

  6. Infectious Dose • Inhalation • Percutaneous (sharps) • Mucous membranes • Ingestion • Animal or arthropod Accident event/transmission route Amount, concentration, form of pathogen • The “source term” • Working cultures • Inocula for animal challenges Amount of infectious inoculum • Atmospheric dilution • Atmospheric stability 6

  7. Infectious Dose • Inhalation • Percutaneous (sharps) • Mucous membranes • Ingestion • Animal or arthropod Accident event/transmission route Amount, concentration, form of pathogen • The “source term” • Working cultures • Inocula for animal challenges Amount of infectious inoculum • Atmospheric dilution • Atmospheric stability Pulmonary infectious dose assumptions: HID50 , HID10 , HID90 Mathematical fit of curves to 3 points; 7

  8. Infectious Dose • Inhalation • Percutaneous (sharps) • Mucous membranes • Ingestion • Animal or arthropod Accident event/transmission route Amount, concentration, form of pathogen • The “source term” • Working cultures • Inocula for animal challenges Amount of infectious inoculum • Atmospheric dilution • Atmospheric stability Pulmonary infectious dose assumptions: HID50 , HID10 , HID90 Mathematical fit of curves to 3 points; Estimated likelihood of initial infection(s) 8

  9. Infectivity

  10. Infectivity

  11. Infectivity

  12. Infectivity ID50 = O.5PFU (95% C.I. 0.3-1.1) via aerosol in rats {Nuzum, 1988 #16358}

  13. Infectivity

  14. Infectivity

  15. Infectivity

  16. Infectivity

  17. Infectivity

  18. Infectivity

  19. Infectivity

  20. Infectivity

  21. Infectivity

  22. Voting

  23. R0- Basic Reproduction Number Definition: The expected number of secondary infections caused by a typical primary case in a fully susceptible population, in the absence of interventions to control the infection and its transmission

  24. Estimates of R0in the literature • Direct estimates from early outbreak data • Before intervention / control measures • Indirect estimates from full outbreak data • Formulas derived from mathematical models

  25. How R0 will be used • Branching process modeling • Simulated, infected individuals transmit to R0 other individuals, on average • Applies in early generations of small outbreak (before intervention measures are implemented) • Individual variation will be included • Accounting for chance and atypical individuals • Compartmental modeling • Value used to constrain other parameters

  26. Proposed R0 values for pathogens • Nominal value proposed for each pathogen • Important notes • Value only applies before control measures • Range of values around nominal value will be tested in sensitivity analyses

  27. Ro

  28. Ro

  29. Ro

  30. Ro

  31. Voting

  32. Infections in the Vulnerable • Problem • Need to account for potential differences in susceptibility to and mortality from infection in specific sub-groups of the population • This is an important concern to the public • Community surrounding the Boston NEIDL site is largely minority and below the poverty line

  33. Vulnerability • Background • Intuitively inferred that certain sub-groups are more susceptible to disease and death from disease • Very young and very old and influenza • Pregnancy and pandemic influenza • Diabetics and pneumonia • HIV/AIDS and tuberculosis • No aggregate estimates available of increased vulnerability to or increased mortality from infections in general

  34. Vulnerability • Request • Estimate increased vulnerability to infection in these sub-groups • Child younger than 5 years of age • Adult older than 65 years of age • A person with diabetes • A person with HIV infection • A pregnant women • Categories: bacteria and viruses • To disease and to mortality • We are requesting a % increase

  35. Vulnerability • How will we use these estimates? • Apply these corrections to estimate increased infection and mortality rate in these scenarios/outputs • Primary exposure to a pathogen • Secondary transmission modeling • Example

  36. Voting

  37. Atmospheric Stability • Needed to assess potential for infections as a result of pathogen releases from the building • Atmospheric conditions may inactivate a portion of the particles released • Range of atmospheric conditions must be considered since releases could occur at any time • Rate of Stability is dependent upon • Temperature (less stable at high temperatures) • UV (less stable in high UV) • Humidity (uncertain affect)

  38. Conversion to Half-Lives • Half-life = t½ = t (ln 2) / ln (No/Nt) • Initial abundance (No) • Abundance at time t (Nt) • Time t • Some data reported as D37 • D37 = Ultra violet light fluence (J/m2) which reduces the abundance to 37% of its original level (i.e., Nt / No = 0.37) • The D37 data were converted to half-lives for discussion

  39. Data Requested • Provide the half-life in minutes for each pathogen for • Cold dry night (maximum half-life) • Hot humid sunny day (minimum half-life) • Many values given in Table 3 of the Briefing reflect lowest stability conditions (i.e., mid-day in summer on sunny day)

  40. Atmospheric Stability

  41. Atmospheric Stability

  42. Atmospheric Stability

  43. Atmospheric Stability

  44. Atmospheric Stability

  45. Voting

More Related